Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2011 AL 2025

Dietary fish oil increases catalase activity in patients with probable Alzheimer's disease

Torres-Mendoza BMG, Ortiz GG, Sánchez-Romero L, Delgado-Lara DLC, García Martínez MT, Mireles-Ramírez MA, Cruz Serrano JA, Pacheco Moisés FP.

Nutr Hosp. 2022 Dec 20;39(6):1364-1368. doi: 10.20960/nh.04153.

Potential of astrocytes in targeting therapy for Alzheimer's disease

Bi W, Lei T, Cai S, Zhang X, Yang Y, Xiao Z, Wang L, Du H.

Int Immunopharmacol. 2022 Dec;113(Pt A):109368. doi: 10.1016/j.intimp.2022.109368. Epub 2022 Oct 29.

Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease

Lane HY, Wang SH, Lin CH.

Psychiatry Clin Neurosci. 2023 Feb;77(2):102-109. doi: 10.1111/pcn.13504. Epub 2022 Nov 24.

Plasmalogens inhibit neuroinflammation and promote cognitive function

Hossain MS, Mawatari S, Fujino T.

Brain Res Bull. 2023 Jan;192:56-61. doi: 10.1016/j.brainresbull.2022.11.005. Epub 2022 Nov 5.

ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies

Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC.

Mol Neurodegener. 2022 Nov 8;17(1):72. doi: 10.1186/s13024-022-00574-4.

Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect

Ferreira I, Rauter AP, Bandarra NM.

Mar Drugs. 2022 Oct 25;20(11):662. doi: 10.3390/md20110662.

Opportunities and challenges for the development of M(1) muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits

Nguyen HTM, van der Westhuizen ET, Langmead CJ, Tobin AB, Sexton PM, Christopoulos A, Valant C.

Br J Pharmacol. 2024 Jul;181(14):2114-2142. doi: 10.1111/bph.15982. Epub 2022 Dec 4.

Hope on the horizon for Alzheimer's disease treatment?

The Lancet Healthy Longevity.

Lancet Healthy Longev. 2022 Nov;3(11):e722. doi: 10.1016/S2666-7568(22)00251-3.

Plasma Exchange in Alzheimer's Disease

Rohrer L, Yunce M, Montine TJ, Shan H.

Transfus Med Rev. 2023 Jan;37(1):10-15. doi: 10.1016/j.tmrv.2022.09.005. Epub 2022 Oct 3.

Astrocytes as a Therapeutic Target in Alzheimer's Disease-Comprehensive Review and Recent Developments

Rodríguez-Giraldo M, González-Reyes RE, Ramírez-Guerrero S, Bonilla-Trilleras CE, Guardo-Maya S, Nava-Mesa MO.

Int J Mol Sci. 2022 Nov 7;23(21):13630. doi: 10.3390/ijms232113630.

Exploring New Vista for Alzheimer's Disease Drug Targets

Kumar D.

Curr Top Med Chem. 2022;22(22):1847-1848. doi: 10.2174/156802662222221007161622.

Pathophysiological mechanism and natural preventive and therapeutic strategies of Alzheimer's disease

Basli A, Bounaas J.

Nutr Health. 2023 Sep;29(3):403-413. doi: 10.1177/02601060221137104. Epub 2022 Nov 14.

Ginsenoside Rg1 in neurological diseases: From bench to bedside

Yang SJ, Wang JJ, Cheng P, Chen LX, Hu JM, Zhu GQ.

Acta Pharmacol Sin. 2023 May;44(5):913-930. doi: 10.1038/s41401-022-01022-1. Epub 2022 Nov 15.

Tau immunotherapy in Alzheimer's disease and progressive supranuclear palsy

Karimi N, Bayram Çatak F, Arslan E, Saghazadeh A, Rezaei N.

Int Immunopharmacol. 2022 Dec;113(Pt B):109445. doi: 10.1016/j.intimp.2022.109445. Epub 2022 Nov 18.

Interventions focusing on learning pre-transfer wheelchair manipulation in a patient with severe Alzheimer's disease: a case report

Nakagawa K, Kanai S, Kitakaze S, Okamura H.

Physiother Theory Pract. 2024 May;40(5):1091-1099. doi: 10.1080/09593985.2022.2149287. Epub 2022 Nov 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias